<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">JOCR</journal-id><journal-title-group><journal-title>Journal of Organic Chemistry Research</journal-title></journal-title-group><issn pub-type="epub">2330-5231</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/JOCR.2017.52010</article-id><article-id pub-id-type="publisher-id">JOCR-20535</article-id><article-categories><subj-group subj-group-type="heading"><subject>JOCR20170200000_11028718.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>化学与材料</subject></subj-group></article-categories><title-group><article-title>
 
 
  离子液体[C
  <sub>2</sub>O
  <sub>2</sub>BBTA][TFA]催化合成3,4-二氢嘧啶-2-(1H)-酮/硫酮
  Synthesis of 3,4-Dihydropyrimidine-2-(1H)- Ones/Thiones Catalyzed by Ionic Liquid [C
  <sub>2</sub>O
  <sub>2</sub>BBTA][TFA]
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>张</surname><given-names>增鹏</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>麻</surname><given-names>荣</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>郭</surname><given-names>磊</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>刘</surname><given-names>晨江</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>石油天然气精细化工教育部&amp;amp;自治区重点实验室，新疆大学理化测试中心，新疆 乌鲁木齐 </addr-line></aff><aff id="aff1"><addr-line>null</addr-line></aff><pub-date pub-type="epub"><day>17</day><month>05</month><year>2017</year></pub-date><volume>05</volume><issue>02</issue><fpage>78</fpage><lpage>85</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  
    无溶剂条件下，阳离子为苯并三唑、阴离子为三氟乙酸根的羧基功能化离子液体作为环境友好的催化剂，高效地合成了一系列3,4-二氢嘧啶-2(1H)-酮或硫酮。此外，离子液体[C
   <sub>2</sub>O
   <sub>2</sub>BBTA][TFA]循环使用至少4次，且催化活性没有明显降低。
    Carboxyl functional ionic liquid with benzotriazole cation and trifluoroacetate anion can be used as environmental-friendly catalyst for the efficient synthesis of 3,4-dihydropyrimidin-2(1H) ones /thiones under solvent-free conditions. Moreover, the ionic liquid [C
   <sub>2</sub>O
   <sub>2</sub>BBTA][TFA] can be easily recycled and reused for at least four cycles without obvious loss of catalytic activity. 
  
 
</p></abstract><kwd-group><kwd>离子液体，催化，无溶剂，3</kwd><kwd>4-二氢嘧啶酮-2(1H)-酮/硫酮, Ionic Liquids</kwd><kwd> Catalysis</kwd><kwd> Solvent-Free</kwd><kwd> 3</kwd><kwd>4-Dihydropyrimidin-2(1H)-Ones/Thiones</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>离子液体[C<sub>2</sub>O<sub>2</sub>BBTA][TFA]催化合成3,4-二氢嘧啶-2-(1H)-酮/硫酮<sup> </sup></title><p>张增鹏，麻荣，郭磊，刘晨江<sup>*</sup></p><p>石油天然气精细化工教育部&amp;自治区重点实验室，新疆大学理化测试中心，新疆 乌鲁木齐</p><disp-formula id="hanspub.20535-formula49"><graphic xlink:href="http://html.hanspub.org/file/2-2970083x5_hanspub.png"  xlink:type="simple"/></disp-formula><p>收稿日期：2017年4月26日；录用日期：2017年5月14日；发布日期：2017年5月17日</p><disp-formula id="hanspub.20535-formula50"><graphic xlink:href="http://html.hanspub.org/file/2-2970083x6_hanspub.png"  xlink:type="simple"/></disp-formula></sec><sec id="s2"><title>摘 要</title><p>无溶剂条件下，阳离子为苯并三唑、阴离子为三氟乙酸根的羧基功能化离子液体作为环境友好的催化剂，高效地合成了一系列3,4-二氢嘧啶-2(1H)-酮或硫酮。此外，离子液体[C<sub>2</sub>O<sub>2</sub>BBTA][TFA]循环使用至少4次，且催化活性没有明显降低。</p><p>关键词 :离子液体，催化，无溶剂，3,4-二氢嘧啶酮-2(1H)-酮/硫酮</p><disp-formula id="hanspub.20535-formula51"><graphic xlink:href="http://html.hanspub.org/file/2-2970083x7_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2017 by authors and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="http://image.hanspub.org:8080\Html/htmlimages\1-2890033x\e70a10f1-7c93-45ea-9603-062237856e4b.png" /><img src="http://image.hanspub.org:8080\Html\htmlimages\1-2890033x\e898c85e-ffc4-45c9-b817-14224a4d6960.png" /></p></sec><sec id="s3"><title>1. 引言</title><p>众所周知，3,4-二氢嘧啶-2(1H)-酮/硫酮化合物具有抗过敏、降压、杀菌、消炎、抗病毒 [<xref ref-type="bibr" rid="hanspub.20535-ref1">1</xref>] - [<xref ref-type="bibr" rid="hanspub.20535-ref6">6</xref>] 及抑制有丝分裂驱动蛋白 [<xref ref-type="bibr" rid="hanspub.20535-ref7">7</xref>] [<xref ref-type="bibr" rid="hanspub.20535-ref8">8</xref>] 等重要的药理和生物活性。100多年前，意大利化学家Biginelli首次提出了浓盐酸催化苯甲醛、尿素和乙酰乙酸乙酯三组分反应合成3,4-二氢嘧啶-2(1H)-酮/硫酮的方法 [<xref ref-type="bibr" rid="hanspub.20535-ref9">9</xref>] 。然而该方法存在条件苛刻、反应时间长(18 h)且产率低(20%~50%)的缺点。因此，各种催化体系被用于该反应以改进经典方法的不足，如多组分聚合物1,4-DHP和3,4-DHPM [<xref ref-type="bibr" rid="hanspub.20535-ref10">10</xref>] 、纳米共催化剂TiO<sub>2</sub>-SiO<sub>2</sub> [<xref ref-type="bibr" rid="hanspub.20535-ref11">11</xref>] 、Cu-EDTA负载的APTMS-Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>核-壳体系 [<xref ref-type="bibr" rid="hanspub.20535-ref12">12</xref>] 、硅钛铝氧化物MxOy [<xref ref-type="bibr" rid="hanspub.20535-ref13">13</xref>] 、微波促进 [<xref ref-type="bibr" rid="hanspub.20535-ref14">14</xref>] 等。</p><p>离子液体因具有蒸气压低、热稳定性好、毒性低、易于回收等诸多优点，在Biginelli反应中也得到了应用 [<xref ref-type="bibr" rid="hanspub.20535-ref15">15</xref>] [<xref ref-type="bibr" rid="hanspub.20535-ref16">16</xref>] 。基于本课题组在离子液体合成和催化应用领域的研究基础 [<xref ref-type="bibr" rid="hanspub.20535-ref17">17</xref>] [<xref ref-type="bibr" rid="hanspub.20535-ref18">18</xref>] ，本文提出了一种Br&#248;nsted酸性苯并三唑离子液体催化合成3,4-二氢嘧啶-2(1H)-酮/硫酮的方法。考察了催化剂种类和用量、反应溶剂、反应时间等因素对反应产率的影响，同时对反应底物的普适性进行了研究。此外，还探讨了离子液体的催化循环使用效果。</p></sec><sec id="s4"><title>2. 实验部分</title><sec id="s4_1"><title>2.1. 试剂与仪器</title><p>薄层层析硅胶用GF254硅胶，柱层析硅胶：300-400目(青岛海洋化工厂)。美国Varian inova-400型核磁共振仪(400 MHz, TMS)；德国Bruker Equinox 55红外光谱仪(KBr压片)；美国HP 1100液相色谱质谱仪；瑞士B&#252;chi B-560型熔点仪。所用试剂均为市售分析纯，用前未经处理。</p></sec><sec id="s4_2"><title>2.2. 离子液体的合成</title><p>离子液体1-丁基-3-羧甲基苯并三唑三氟乙酸盐的合成如式1所示。将0.20 mol的1-丁基苯并三唑和0.24 mol的1-氯乙酸在90℃搅拌反应36 h，冷却至室温，用乙醚和丙酮(V:V = 2:1, 3 &#215; 20 mL)混合溶剂浸泡洗涤所得的棕色固体，抽滤，所得固体在90℃下真空干燥10 h，即得氯化1-丁基-3-羧甲基苯并三唑 [<xref ref-type="bibr" rid="hanspub.20535-ref19">19</xref>] ，白色固体，熔点：148℃~149℃。</p><p>在室温下，将0.012 mol三氟乙酸缓慢滴加到0.01 mol氯化1-丁基-3-羧甲基苯并三唑中，滴毕升温至80℃回流反应48 h，得到褐色液体，减压旋除过量的三氟乙酸，残余物在90℃下真空干燥10 h，即得离子液体1-丁基-3-羧甲基苯并三唑三氟乙酸盐[C<sub>2</sub>O<sub>2</sub>BBTA][TFA]。</p><p>离子液体[C<sub>2</sub>O<sub>2</sub>BBTA][TFA]表征数据：褐色液体，[C<sub>2</sub>O<sub>2</sub>BBTA][TFA]：<sup>1</sup>H NMR (400 MHz, DMSO) δ: 8.79-8.24 (m, 3H), 8.06-7.96 (m, 2H), 5.93 (s, 2H), 5.08 (t, J = 7.1 Hz, 2H), 2.06-1.99 (m, 2H), 1.39-1.31 (m,</p><disp-formula id="hanspub.20535-formula52"><graphic xlink:href="http://html.hanspub.org/file/2-2970083x10_hanspub.png"  xlink:type="simple"/></disp-formula><p>Scheme 1. The synthesis of ionic liquid [C<sub>2</sub>O<sub>2</sub>BBTA][TFA]</p><p>图式1. 离子液体[C<sub>2</sub>O<sub>2</sub>BBTA][TFA]的合成</p><p>2H), 0.93 (t, J = 7.4 Hz, 3H), <sup>13</sup>C NMR (100 MHz, DMSO) δ: 166.26 134.99, 134.22, 131.13, 130.80, 120.96, 117.76, 114.22, 113.85, 52.66, 51.09, 30.27, 18.81, 13.09. IR (KBr, ν/cm-1): 3106, 2967, 2940, 2879, 2511, 1738, 1505, 1471, 1364, 1190, 1141, 1029, 754, 718, 643, 599. ESI-MS: m/z (%) = 234.1 (100%) [M + H] <sup>+</sup>.</p></sec><sec id="s4_3"><title>2.3. 未知化合物4a-4s的合成及结构分析</title><p>化合物4a-4r的合成反应如图式2所示。在10 mL圆底烧瓶中加入2 mmol芳香醛、2 mmol β-二羰基化合物和3 mmol脲或硫脲，20 mol%催化剂[C<sub>2</sub>O<sub>2</sub>BBTA][TFA]，混合均匀后在90℃无溶剂条件下磁力搅拌反应40 min。反应结束后，向混合物中加入大量的碎冰，室温充分搅拌至碎冰融化，过滤即得产物粗品，经过柱层析分离得化合物4a-4r纯品。化合物结构经<sup>1</sup>H NMR，<sup>13</sup>C NMR，IR和MS确证结构。</p><p>目标化合物的表征如下：</p><p>4g：白色固体；<sup>1</sup>H NMR (400 MHz, DMSO-d<sub>6</sub>), δ: 9.30 (s, 1H), 7.74 (s, 1H), 7.36 (ddd, J = 15.0, 8.8, 4.4 Hz, 2H), 7.21 (d, J = 2.5 Hz, 1H), 5.60 (d, J = 2.8 Hz, 1H), 3.90 (q, J = 7.1 Hz, 2H), 2.30 (s, 3H), 1.00 (t, J = 7.1 Hz, 3H); <sup>13</sup>C NMR (100 MHz, DMSO-d<sub>6</sub>) δ: 164.76, 162.01, 159,55, 151.10, 149.30, 138.29, 138.26, 132.28, 130.27, 130.17, 116.34, 116.09, 114.97, 97.63, 58.99, 50.91, 40.02, 17.56, 13.81; IR (KBr, ν/cm<sup>-1</sup>): 3346, 3225, 3112, 2976, 1697, 1644, 1223, 1093, 903, 805; ESI-MS: m/z (%) = 335.0 (100%) [M +Na]<sup> +</sup>.</p><p>4h：白色固体；<sup>1</sup>H NMR (400 MHz, DMSO-d<sub>6</sub>),<sup> </sup>δ: 9.32 (s, 1H), 7.78 (s, 1H), 7.48 (dd, J = 8.8, 5.2 Hz, 1H), 7.23 – 6.92 (m, 2H), 5.59 (s, 1H), 3.91 (q, J = 7.1 Hz, 2H), 2.30 (s, 3H), 1.00 (t, J = 7.1 Hz, 3H); <sup>13</sup>C NMR (100 MHz, DMSO-d<sub>6</sub>), δ: 164.71, 162.18, 159.75, 151.00, 149.73, 143.89, 143.83, 131.17, 131.09, 126.86, 116.28, 115.27, 115.03, 97.11, 59.04, 51.76, 17.60, 13.78; IR (KBr, ν/cm<sup>-1</sup>): 3221, 3098, 2982, 1703, 1650, 1604, 1282, 1237, 1103, 881, 803; ESI-MS: m/z (%) = 335.0 (100%) [M + Na]<sup> +</sup>.</p><p>4i：白色固体；<sup>1</sup>H NMR (400 MHz, DMSO) δ: 9.30 (s, 1H), 7.79 (s, 1H), 7.49 (dd, J = 6.7, 2.2 Hz, 1H), 7.35 (t, J = 8.7 Hz, 1H), 7.27 (dd, J = 4.9, 2.2 Hz, 1H), 5.15 (d, J = 3.3 Hz, 1H), 4.18 – 3.86 (m, 2H), 2.26 (s, 3H), 1.10 (t, J = 7.1 Hz, 3H); <sup>13</sup>C NMR (100 MHz, DMSO-d<sub>6</sub>), δ: 165.00, 158.49, 156.06, 151.66, 148.95, 142.90, 142.87, 131.19, 127.48, 127.40, 116.86, 116.64, 107.63, 107.42, 98.42, 59.21, 52.97, 17.72, 13.93, IR (KBr, ν/cm<sup>-1</sup>): 3342, 3203, 3100, 2984, 1702, 1658, 1232, 1099, 895, 804; ESI-MS: m/z (%) = 379.0 (100%) [M + Na]<sup> +</sup>.</p><p>4m：白色固体；<sup>1</sup>H NMR (400 MHz, DMSO-d<sub>6</sub>), δ: 9.15 (s, 1H), 7.70 (s, 1H), 7.24 (t, H), 6.76-6.83 (m, 3H), 5.10 (s, 1H), 4.82 (m, 1H), 3.72 (s, 3H), 2.23 (s, 3H), 1.16 (d, J = 8.0 Hz, 3H), 1.01 (d, J = 8.0, 3H); <sup>13</sup>C NMR (100 MHz, DMSO-d<sub>6</sub>), δ: 164.73, 159.07, 152.07, 148.05, 146.35, 129.37, 118.20, 112.33, 112.00, 99.34, 66.25, 54.86, 53.73, 21.69, 21.40, 17.60, IR (KBr, ν/cm<sup>-1</sup>): 3234, 3106, 2981, 2948, 1721, 1652, 1599, 1463, 1431, 1374, 1282, 1232, 1092, 1073, 788; ESI-MS: m/z (%) = 327.1 (100%) [M + Na]<sup> +</sup>.</p><disp-formula id="hanspub.20535-formula53"><graphic xlink:href="http://html.hanspub.org/file/2-2970083x11_hanspub.png"  xlink:type="simple"/></disp-formula><p>Scheme 2. Synthesis of 3,4-dihydropyrimidin-2(1H)-ones/thiones (4a-4r)</p><p>图式2. 3,4-二氢嘧啶酮/硫酮(4a-4r)的合成</p><p>4n：橙色固体；<sup>1</sup>H NMR (400 MHz, DMSO-d<sub>6</sub>), δ: 9.32 (s, 1H), 9.07 (s, 1H), 7.59 (s, 1H), 7.02 (d, J = 4.0 Hz, 2H), 6.68 (d, J = 4.0 Hz, 2H), 5.02 (s, 1H), 4.82-4.78 (m, 1H), 2.22 (s, 3H), 1.15 (d, J = 6.4 Hz, 3H), 1.00 (d, J = 6.4 Hz, 3H); <sup>13</sup>C NMR (100 MHz, DMSO-d<sub>6</sub>), δ: 164.79, 156.39, 152.03, 147.35, 135.47, 127.35, 114.80, 99.92, 66.10, 53.44, 21.69, 21.39, 17.56; IR (KBr, ν/cm<sup>-1</sup>): 3289, 3227, 3109, 2979, 2808, 1706, 1686, 1651, 1511, 1448, 1371, 1282, 1226, 1173, 1086, 783, 680; ESI-MS: m/z (%) = 313.1 (100%) [M + Na]<sup> +</sup>.</p><p>4o：绿色固体；<sup>1</sup>H NMR (400 MHz, DMSO-d<sub>6</sub>), δ: 9.05 (s, 1H), 7.56 (s, 1H), 7.03 (d, J = 4.0 Hz, 2H), 6.65 (d, J = 4.0 Hz, 2H), 5.01 (s, 1H), 4.82-4.80 (m, 1H), 2.84 (s, 6H), 2.22(s, 3H), 1.17 (d, J = 6.0 Hz, 3H), 1.03 (d, J = 6.0 Hz, 3H); <sup>13</sup>C NMR (100 MHz, DMSO-d<sub>6</sub>), δ: 164.87, 152.17, 149.62, 147.15, 132.80, 126.80, 112.04, 100.12, 66.08, 53.25, 21.72, 21.47, 17.56; IR (KBr, ν/cm<sup>-1</sup>): 3243, 3116, 2980, 2937, 1719, 1648, 1526, 1457, 1363, 1290, 1231, 1090, 789; ESI-MS: m/z (%) = 340.1 (100%) [M + Na]<sup> +</sup>.</p><p>4p：淡黄色固体；<sup>1</sup>H NMR (400 MHz, DMSO-d<sub>6</sub>), δ: 9.10 (s, 1H), 7.67 (s, 1H), 7.22-7.26 (m, 2H), 7.13-7.14 (m, 2H), 5.08 (s, 1H), 2.21 (s, 3H), 1.28 (s, 9H); <sup>13</sup>C NMR (100 MHz, DMSO-d<sub>6</sub>), δ: 164.61, 162.38, 159.97, 151.81, 147.44, 141.16, 141.13, 128.20, 128.13, 115.03, 114.82, 100.25, 79.10, 53.60, 27.72, 17.56; IR (KBr, ν/cm<sup>-1</sup>): 3230, 3107, 2975, 2930, 1697, 1644, 1507, 1452, 1366, 1292, 1230, 1164, 1090, 1035, 837, 798, 759, 658; ESI-MS: m/z (%) = 329.1 (100%) [M + Na]<sup> +</sup>.</p><p>4q：淡黄色固体；<sup>1</sup>H NMR (400 MHz, DMSO-d<sub>6</sub>) δ: 9.05 (d, J = 1.6 Hz, 1H), 7.64 – 7.63 (m, 1H), 7.23-7.21 (m, 1H), 7.06 – 7.02 (m, 3H), 5.07 (d, J = 3.2 Hz, 1H), 2.28 (s, 3H), 2.21 (s, 3H), 1.29 (s, 9H); <sup>13</sup>C NMR (100 MHz, DMSO-d<sub>6</sub>), δ: 164.73, 152.06, 147.05, 144.89, 137.07, 128.13, 127.68, 126.80, 123.23, 100.50, 78.99, 54.20, 27.73, 21.01, 17.56; IR (KBr, ν/cm<sup>-1</sup>): 3226, 3099, 2977, 2935, 1699, 1647, 1489, 1438, 1366, 1294, 1232, 1165, 1087, 859, 813, 774, 745, 697,670,599; ESI-MS: m/z (%) = 325.1 (100%) [M + Na]<sup> +</sup>.</p><p>4r：淡黄色固体；<sup>1</sup>H NMR (400 MHz, DMSO-d<sub>6</sub>), δ: 9.08 (s, 1H,); 7.68 – 7.67 (m, 1H), 7.25 (t, J = 8.0 Hz, 1H), 6.83 – 6.78 (m, 3H), 5.08 (d, J = 3.2 Hz, 1H), 3.73 (s, 3H), 2.22 (s, 3H), 1.31 (s, 9H); <sup>13</sup>C NMR (100 MHz, DMSO-d<sub>6</sub>), δ: 164.74, 159.07, 152.14, 147.29, 146.36, 129.35, 118.14, 112.26, 111.98, 100.35, 79.05, 54.85, 53.95, 27.74, 17.57; IR (KBr, ν/cm<sup>-1</sup>): 3392, 3247, 3111, 2972, 2937, 1707, 1672, 1519, 1463, 1366, 1282, 1240, 1165, 1094, 1038, 849, 801; ESI-MS: m/z (%) = 341.1 (100%) [M + Na]<sup> +</sup>.</p></sec></sec><sec id="s5"><title>3. 结果与讨论</title><sec id="s5_1"><title>3.1. 最优反应条件的筛选</title><p>以苯甲醛、乙酰乙酸乙酯和脲三组分反应为模型，考察了催化剂种类和用量、溶剂种类、反应时间等因素对反应的影响。首先考察了2种不同阴离子的1-丁基-3-羧甲基苯并三唑离子液体及相应Br&#248;nsted酸三氟乙酸对反应的影响(表1, entries 1-3)。从表中可以看出，离子液体[C<sub>2</sub>O<sub>2</sub>BBTA][TFA]的催化活性优于离子液体[C<sub>2</sub>O<sub>2</sub>BBTA]Cl和三氟乙酸。其次，考察了催化剂的用量对反应体系的影响(表1, entries 4, 5)，发现催化剂用量为20 mol%时，产物产率最高为96%。随后考察了H<sub>2</sub>O、CH<sub>3</sub>OH、C<sub>2</sub>H<sub>5</sub>OH、i-PrOH、</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Optimization of reaction conditions</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Entry</th><th align="center" valign="middle" >Catalyst</th><th align="center" valign="middle" >Solvent</th><th align="center" valign="middle" >Time</th><th align="center" valign="middle" >Yield (%)<sup>b</sup></th></tr></thead><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >[C<sub>2</sub>O<sub>2</sub>BBTA]Cl (20% mol)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >40 min</td><td align="center" valign="middle" >85</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >[C<sub>2</sub>O<sub>2</sub>BBTA][TFA] (20% mol)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >40 min</td><td align="center" valign="middle" >96</td></tr><tr><td align="center" valign="middle" >3</td><td align="center" valign="middle" >CF<sub>3</sub>COOH (20% mol)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >40 min</td><td align="center" valign="middle" >96</td></tr><tr><td align="center" valign="middle" >4</td><td align="center" valign="middle" >[C<sub>2</sub>O<sub>2</sub>BBTA][TFA] (10% mol)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >40 min</td><td align="center" valign="middle" >85</td></tr><tr><td align="center" valign="middle" >5</td><td align="center" valign="middle" >[C<sub>2</sub>O<sub>2</sub>BBTA][TFA] (30% mol)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >40 min</td><td align="center" valign="middle" >95</td></tr><tr><td align="center" valign="middle" >6</td><td align="center" valign="middle" >[C<sub>2</sub>O<sub>2</sub>BBTA][TFA] (20% mol)</td><td align="center" valign="middle" >H<sub>2</sub>O</td><td align="center" valign="middle" >40 min</td><td align="center" valign="middle" >5</td></tr><tr><td align="center" valign="middle" >7</td><td align="center" valign="middle" >[C<sub>2</sub>O<sub>2</sub>BBTA][TFA] (20% mol)</td><td align="center" valign="middle" >MeOH</td><td align="center" valign="middle" >40 min</td><td align="center" valign="middle" >6</td></tr><tr><td align="center" valign="middle" >8</td><td align="center" valign="middle" >[C<sub>2</sub>O<sub>2</sub>BBTA][TFA] (20% mol)</td><td align="center" valign="middle" >EtOH</td><td align="center" valign="middle" >40 min</td><td align="center" valign="middle" >10</td></tr><tr><td align="center" valign="middle" >9</td><td align="center" valign="middle" >[C<sub>2</sub>O<sub>2</sub>BBTA][TFA] (20% mol)</td><td align="center" valign="middle" >i-PrOH</td><td align="center" valign="middle" >40 min</td><td align="center" valign="middle" >48</td></tr><tr><td align="center" valign="middle" >10</td><td align="center" valign="middle" >[C<sub>2</sub>O<sub>2</sub>BBTA][TFA] (20% mol)</td><td align="center" valign="middle" >CH<sub>2</sub>Cl<sub>2</sub></td><td align="center" valign="middle" >40 min</td><td align="center" valign="middle" >16</td></tr><tr><td align="center" valign="middle" >11</td><td align="center" valign="middle" >[C<sub>2</sub>O<sub>2</sub>BBTA][TFA] (20% mol)</td><td align="center" valign="middle" >CH<sub>3</sub>CN</td><td align="center" valign="middle" >40 min</td><td align="center" valign="middle" >19</td></tr><tr><td align="center" valign="middle" >12</td><td align="center" valign="middle" >[C<sub>2</sub>O<sub>2</sub>BBTA][TFA] (20% mol)</td><td align="center" valign="middle" >DMF</td><td align="center" valign="middle" >40 min</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >13</td><td align="center" valign="middle" >[C<sub>2</sub>O<sub>2</sub>BBTA][TFA] (20% mol)</td><td align="center" valign="middle" >Toluene</td><td align="center" valign="middle" >40 min</td><td align="center" valign="middle" >5</td></tr><tr><td align="center" valign="middle" >14</td><td align="center" valign="middle" >[C<sub>2</sub>O<sub>2</sub>BBTA][TFA] (20% mol)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >50 min</td><td align="center" valign="middle" >91</td></tr><tr><td align="center" valign="middle" >15</td><td align="center" valign="middle" >[C<sub>2</sub>O<sub>2</sub>BBTA][TFA] (20% mol)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >60 min</td><td align="center" valign="middle" >93</td></tr><tr><td align="center" valign="middle" >16</td><td align="center" valign="middle" >[C<sub>2</sub>O<sub>2</sub>BBTA][TFA] (20% mol)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >30 min</td><td align="center" valign="middle" >94</td></tr><tr><td align="center" valign="middle" >17</td><td align="center" valign="middle" >[C<sub>2</sub>O<sub>2</sub>BBTA][TFA] (20% mol)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >20 min</td><td align="center" valign="middle" >91</td></tr></tbody></table></table-wrap><p>表1. 反应条件的优化<sup>a</sup></p><disp-formula id="hanspub.20535-formula54"><graphic xlink:href="http://html.hanspub.org/file/2-2970083x12_hanspub.png"  xlink:type="simple"/></disp-formula><p><sup>a</sup>反应条件：苯甲醛(2 mmol)，乙酰乙酸乙酯(2 mmol)，脲(3 mmol) %，90℃；<sup>b</sup>分离产率。</p><p>CH<sub>2</sub>Cl<sub>2</sub>、CH<sub>3</sub>CN、DMF、甲苯等八种溶剂及无溶剂条件下反应的效果，发现无溶剂条件下反应效果最佳(表1, entries 6-13)。最后我们对反应时间进行了筛选(表1, entries 14-17)，结果表明最佳反应时间是40 min。因此，最优的反应条件为：无溶剂条件下，离子液体[C<sub>2</sub>O<sub>2</sub>BBTA][TFA](20 mol%)为催化剂，90℃反应40 min。</p></sec><sec id="s5_2"><title>3.2. 底物普适性研究</title><p>在最优条件下，我们对该反应的底物普适性进行了研究，结果见表2。从中可以看出，苯甲醛的苯环上不管是带有供电子基团还是吸电子基团，都能顺利的参与反应，以82%~98%的收率得到相应的3,4-二氢嘧啶-2(1H)-酮产物(表2, entries 4a-4j)。硫脲代替脲也被用于Biginelli三组分反应，成功地合成了相应的产物(表2, entries 4k, 4l)。使用乙酰乙酸异丙酯、乙酰乙酸叔丁酯代替1,3-二羰基化合物参与反应也能得到令人满意的结果，相应产物的产率为89%~99% (表2, entries 4m-4r)。因此，离子液体1-丁基-3-羧甲基苯并三唑三氟乙酸盐催化合成二氢嘧啶-2(1H)-酮/硫酮化合物具有很好的底物普适性。</p></sec><sec id="s5_3"><title>3.3. 离子液体循环使用性</title><p>离子液体的特性之一是循环使用，本文以苯甲醛、乙酰乙酸乙酯和脲三组分反应为模型，在最优条件下考察了离子液体催化剂1-丁基-3-羧甲基苯并三唑三氟乙酸盐的循环使用效果。具体方法为：将反应结束萃取分离的水相减压旋除水，残余物经真空干燥至恒重，即得回收的离子液体[C<sub>2</sub>O<sub>2</sub>BBTA][TFA]，可直接用于下一次催化循环。从图1可知，离子液体催化剂1-丁基-3-羧甲基苯并三唑三氟乙酸盐循环使用4次后仍能保持较好的催化活性，表明该离子液体具有较好的循环使用效果。</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Investigation of substrate scope</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Entry</th><th align="center" valign="middle"  rowspan="2"  >R<sup>1</sup></th><th align="center" valign="middle"  rowspan="2"  >R<sup>2</sup></th><th align="center" valign="middle"  rowspan="2"  >X</th><th align="center" valign="middle"  rowspan="2"  >Yields<sup>b</sup> (%)</th><th align="center" valign="middle"  colspan="2"  >Mp (℃)<sup>c</sup></th></tr></thead><tr><td align="center" valign="middle" >Found</td><td align="center" valign="middle" >Reported (lit.)</td></tr><tr><td align="center" valign="middle" >4a</td><td align="center" valign="middle" >C<sub>6</sub>H<sub>5</sub></td><td align="center" valign="middle" >EtO</td><td align="center" valign="middle" >O</td><td align="center" valign="middle" >96</td><td align="center" valign="middle" >201-202</td><td align="center" valign="middle" >200-202 [<xref ref-type="bibr" rid="hanspub.20535-ref20">20</xref>]</td></tr><tr><td align="center" valign="middle" >4b</td><td align="center" valign="middle" >4-Me-C<sub>6</sub>H<sub>4</sub></td><td align="center" valign="middle" >EtO</td><td align="center" valign="middle" >O</td><td align="center" valign="middle" >97</td><td align="center" valign="middle" >209-211</td><td align="center" valign="middle" >209-212 [<xref ref-type="bibr" rid="hanspub.20535-ref21">21</xref>]</td></tr><tr><td align="center" valign="middle" >4c</td><td align="center" valign="middle" >3-MeO-C<sub>6</sub>H<sub>4</sub></td><td align="center" valign="middle" >EtO</td><td align="center" valign="middle" >O</td><td align="center" valign="middle" >93</td><td align="center" valign="middle" >219-221</td><td align="center" valign="middle" >219-220 [<xref ref-type="bibr" rid="hanspub.20535-ref20">20</xref>]</td></tr><tr><td align="center" valign="middle" >4d</td><td align="center" valign="middle" >4-F-C<sub>6</sub>H<sub>4</sub></td><td align="center" valign="middle" >EtO</td><td align="center" valign="middle" >O</td><td align="center" valign="middle" >98</td><td align="center" valign="middle" >175-176</td><td align="center" valign="middle" >175-177 [<xref ref-type="bibr" rid="hanspub.20535-ref22">22</xref>]</td></tr><tr><td align="center" valign="middle" >4e</td><td align="center" valign="middle" >2-Cl-C<sub>6</sub>H<sub>4</sub></td><td align="center" valign="middle" >EtO</td><td align="center" valign="middle" >O</td><td align="center" valign="middle" >93</td><td align="center" valign="middle" >211-213</td><td align="center" valign="middle" >211-213 [<xref ref-type="bibr" rid="hanspub.20535-ref23">23</xref>]</td></tr><tr><td align="center" valign="middle" >4f</td><td align="center" valign="middle" >2-Br-C<sub>6</sub>H<sub>4</sub></td><td align="center" valign="middle" >EtO</td><td align="center" valign="middle" >O</td><td align="center" valign="middle" >93</td><td align="center" valign="middle" >202-204</td><td align="center" valign="middle" >205-207 [<xref ref-type="bibr" rid="hanspub.20535-ref24">24</xref>]</td></tr><tr><td align="center" valign="middle" >4g</td><td align="center" valign="middle" >2-Cl-4-F-C<sub>6</sub>H<sub>3</sub></td><td align="center" valign="middle" >EtO</td><td align="center" valign="middle" >O</td><td align="center" valign="middle" >88</td><td align="center" valign="middle" >195-197</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >4h</td><td align="center" valign="middle" >2-Cl-5-F-C<sub>6</sub>H<sub>3</sub></td><td align="center" valign="middle" >EtO</td><td align="center" valign="middle" >O</td><td align="center" valign="middle" >82</td><td align="center" valign="middle" >219-221</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >4i</td><td align="center" valign="middle" >3-Br-4-F-C<sub>6</sub>H<sub>3</sub></td><td align="center" valign="middle" >EtO</td><td align="center" valign="middle" >O</td><td align="center" valign="middle" >85</td><td align="center" valign="middle" >193-195</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >4j</td><td align="center" valign="middle" >3,4-(HO)<sub>2</sub>-C<sub>6</sub>H<sub>3</sub></td><td align="center" valign="middle" >EtO</td><td align="center" valign="middle" >O</td><td align="center" valign="middle" >89</td><td align="center" valign="middle" >232-234</td><td align="center" valign="middle" >233-235 [<xref ref-type="bibr" rid="hanspub.20535-ref20">20</xref>]</td></tr><tr><td align="center" valign="middle" >4k</td><td align="center" valign="middle" >C<sub>6</sub>H<sub>5</sub></td><td align="center" valign="middle" >EtO</td><td align="center" valign="middle" >S</td><td align="center" valign="middle" >83</td><td align="center" valign="middle" >201-204</td><td align="center" valign="middle" >202-204 [<xref ref-type="bibr" rid="hanspub.20535-ref25">25</xref>]</td></tr><tr><td align="center" valign="middle" >4l</td><td align="center" valign="middle" >4-Me-C<sub>6</sub>H<sub>4</sub></td><td align="center" valign="middle" >EtO</td><td align="center" valign="middle" >S</td><td align="center" valign="middle" >90</td><td align="center" valign="middle" >184-186</td><td align="center" valign="middle" >185-186 [<xref ref-type="bibr" rid="hanspub.20535-ref26">26</xref>]</td></tr><tr><td align="center" valign="middle" >4m</td><td align="center" valign="middle" >3-MeO-C<sub>6</sub>H<sub>4</sub></td><td align="center" valign="middle" >i-PrO</td><td align="center" valign="middle" >O</td><td align="center" valign="middle" >94</td><td align="center" valign="middle" >196-198</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >4n</td><td align="center" valign="middle" >4-HO-C<sub>6</sub>H<sub>4</sub></td><td align="center" valign="middle" >i-PrO</td><td align="center" valign="middle" >O</td><td align="center" valign="middle" >98</td><td align="center" valign="middle" >192-194</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >4o</td><td align="center" valign="middle" >4-N(CH<sub>3</sub>)<sub>2</sub>-C<sub>6</sub>H<sub>4</sub></td><td align="center" valign="middle" >i-PrO</td><td align="center" valign="middle" >O</td><td align="center" valign="middle" >89</td><td align="center" valign="middle" >260-263</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >4p</td><td align="center" valign="middle" >4-F-C<sub>6</sub>H<sub>4</sub></td><td align="center" valign="middle" >t-BuO</td><td align="center" valign="middle" >O</td><td align="center" valign="middle" >99</td><td align="center" valign="middle" >147-149</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >4q</td><td align="center" valign="middle" >3-Me-C<sub>6</sub>H<sub>4</sub></td><td align="center" valign="middle" >t-BuO</td><td align="center" valign="middle" >O</td><td align="center" valign="middle" >93</td><td align="center" valign="middle" >217-219</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >4r</td><td align="center" valign="middle" >3-MeO-C<sub>6</sub>H<sub>4</sub></td><td align="center" valign="middle" >t-BuO</td><td align="center" valign="middle" >O</td><td align="center" valign="middle" >95</td><td align="center" valign="middle" >212-214</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>表2. 底物普适性研究<sup>a</sup></p><disp-formula id="hanspub.20535-formula55"><graphic xlink:href="http://html.hanspub.org/file/2-2970083x13_hanspub.png"  xlink:type="simple"/></disp-formula><p><sup>a</sup>反应条件：芳香醛(2 mmol)，1,3-二羰基化合物(2 mmol)，脲或硫脲(3 mmol)，[C<sub>2</sub>O<sub>2</sub>BBTA][TFA] (20 mol%)，90℃，40 min；<sup>b</sup>分离产率。</p><p>图1. 离子液体[C<sub>2</sub>O<sub>2</sub>BBTA][TFA]的循环使用研究</p></sec></sec><sec id="s6"><title>4. 结论</title><p>本文发展了一种离子液体1-丁基-3-羧甲基苯并三唑三氟乙酸盐催化芳香醛、1,3-二羰基化合物和脲或硫脲绿色、高效合成3,4-二氢嘧啶-2(1H)-酮或硫酮的方法。该方法具有对环境友好、反应时间短、产率高等优点，离子液体催化剂可循环使用4次并且活性没有明显降低。</p></sec><sec id="s7"><title>基金项目</title><p>国家自然科学基金(No. 21572195, 21262035, 21162025)。</p></sec><sec id="s8"><title>文章引用</title><p>张增鹏,麻 荣,郭 磊,刘晨江. 离子液体[C<sub>2</sub>O<sub>2</sub>BBTA][TFA]催化合成3,4-二氢嘧啶-2-(1H)-酮/硫酮Synthesis of 3,4-Dihydropyrimidine-2-(1H)- Ones/Thiones Catalyzed by Ionic Liquid [C<sub>2</sub>O<sub>2</sub>BBTA][TFA][J]. 有机化学研究, 2017, 05(02): 78-85. http://dx.doi.org/10.12677/JOCR.2017.52010</p></sec><sec id="s9"><title>参考文献 (References)</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.20535-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Atwalk, K.S., Rovnyak, G.C., Kimball, S.D., et al. (1990) Dihydropyrimidine Calcium Channel Blockers. II. 3-Sub- stituted-4-Aryl-1,4-Dihydro-6-Methyl-5-Pyrimidinecarboxylic Acid Esters as Potent Mimics of Dihydropyridines. Journal of Medicinal Chemistry, 33, 2629-2635. &lt;br&gt;https://doi.org/10.1021/jm00171a044</mixed-citation></ref><ref id="hanspub.20535-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Kappe, C.O. (1993) 100 Years of the Biginelli Dihydropyrimidine Synthesis. Tetrahedron, 49, 6937-6963.</mixed-citation></ref><ref id="hanspub.20535-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Overman, L.E., Rabinowitz, M.H. and Renhowe, P.A. (1995) Enantioselective Total Synthesis of (-)-Ptilomycalin A. Journal of the American Chemical Society, 117, 2657-2658. &lt;br&gt;https://doi.org/10.1021/ja00114a034</mixed-citation></ref><ref id="hanspub.20535-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Snider, B.B., Chen, J., Patil, A.D. and Freyer, A.J. (1996) Synthesis of the Tricyclic Portions of Batzelladines A, B and D. Revision of the Stereochemistry of Batzelladines A and D. Tetrahedron Letters, 37, 6977-6980.</mixed-citation></ref><ref id="hanspub.20535-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Kappe, C.O., Fabian, W.M.F. and Semones, M.A. (1997) Conformational Analysis of 4-Aryl-Dihydropyrimidine Calcium Channel Modulators. A Comparison of ab Initio, Semiempirical and X-Ray Crystallographic Studies. Tetrahedron, 53, 2803-2816.</mixed-citation></ref><ref id="hanspub.20535-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Yang, Z.Y. and Guo, H.Y. (2011) One-Pots Synthesis of 3,4-Dihydropyrimidin-2-(1H)-Ones Catalyzed by Acidic Ionic Liquid under Solvent-Free Conditions. Journal of Zhejiang University of Technology, 39, 511-515.</mixed-citation></ref><ref id="hanspub.20535-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Mayer, T.U., Kapoor, T.M., Haggarty, S.J., et al. (1999) Small Molecule Inhibitor of Mitotic Spindle Bipolarity Identified in a Phenotype-Based Screen. Science, 286, 971-974. &lt;br&gt;https://doi.org/10.1126/science.286.5441.971</mixed-citation></ref><ref id="hanspub.20535-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Deres, K., Schröder, C.H., Paessens, A., et al. (2003) Inhibition of Hepatitis B Virus Replication by Drug-Induced Depletion of Nucleocapsids. Science, 299, 893-896. &lt;br&gt;https://doi.org/10.1126/science.1077215</mixed-citation></ref><ref id="hanspub.20535-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Li, X., Liu, C, Wang, J. and Li, Y. (2009) Lanthanum Nitrate as an Efficient Catalyst for the Synthesis of 3,4-Dihydro- pyrimidine-2(1H)-(Thio)Ones. Chemistry, 9, 837-840.</mixed-citation></ref><ref id="hanspub.20535-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Wu, H., Fu, C., Zhao, Y., Yang, B., Wei, Y., Wang, Z. and Tao, L. (2015) Multicomponent Copolycondensates via the Simultaneous Hantzsch and Biginelli Reactions. ACS Macro Letters, 4, 1189-1193.  
&lt;br&gt;https://doi.org/10.1021/acsmacrolett.5b00637</mixed-citation></ref><ref id="hanspub.20535-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Titova, Y., Fedorova, O., Rusinov, G., Vigorov, A., Krasnov, V., Murashkevich, A. and Charushin, V. (2015) Effect of Nanosized TiO2-SiO2 Covalently Modified by Chiral Mole-cules on the Asymmetric Biginelli Reaction. Catalysis Today, 241, 270-274.</mixed-citation></ref><ref id="hanspub.20535-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Sheykhan, M., Yahyazadeh, A. and Rahemizadeh, Z. (2016) Cu-EDTA-Modified APTMS-Fe3O4@SiO2 Core-Shell Nanocatalyst: A Novel Magnetic Re-coverable Catalyst for the Biginelli Reaction. RSC Advances, 6, 34553-34563.  
&lt;br&gt;https://doi.org/10.1039/C6RA02415G</mixed-citation></ref><ref id="hanspub.20535-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Fedorova, O.V., Titova, Y.A., Vigorov, A.Y., Toporova, M.S., Alisienok, O.A., Murashkevich, A.N., Krasnov, V.P., Rusinov, G.L. and Charushin, V.N. (2016) Asymmetric Biginelli Reaction Catalyzed by Silicon, Titanium and Aluminum Oxides. Catalysis Letters, 146, 493-498. &lt;br&gt;https://doi.org/10.1007/s10562-015-1666-5</mixed-citation></ref><ref id="hanspub.20535-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Kefayati, H., Mirfarhadi, S.M. and Kazemi-Rad, R. (2015) Un-expected One-Pot Synthesis of Novel 2-Aminopyrimi- dine-4-Ones under Microwave Irradiation. Journal of the Chemistry Communication, 62, 107-111.  
&lt;br&gt;https://doi.org/10.1002/jccs.201400248</mixed-citation></ref><ref id="hanspub.20535-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Mohammadi, K., Shirini, F. and Yahyazadeh, A. (2015) 1,3-Disulfonic Acid Imidazolium Hydrogen Sulfate: A Reusable and Efficient Ionic Liquid for the One-Pot Mul-ti-Component Synthesis of Pyrimido[4,5-b]Quinoline Derivatives. RSC Advances, 5, 23586-23590. &lt;br&gt;https://doi.org/10.1039/C5RA02198G</mixed-citation></ref><ref id="hanspub.20535-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Elhamifar, D., Nasr-Esfahani, M, Karimi, B., Moshkelgosha, R. and Shábani, A. (2016) Ionic Liquid and Sulfonic Acid Based Bifunctional Periodic Mesoporous Organosilica (BPMO-IL-SO3H) as a Highly Efficient and Reusable Nanocatalyst for the Biginelli Reaction. ChemCatChem, 6, 2593-2599.</mixed-citation></ref><ref id="hanspub.20535-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Zhang, Y.H., Wang, B., Zhang, X.M., Huang, J.B. and Liu, C.J. (2015) An Efficient Synthesis of 3,4-Dihydropyrimi- din-2(1H)-Ones and Thiones Catalyzed by a Novel Brønsted Acidic Ionic Liquid under Solvent-Free Conditions. Molecules, 20, 3811-3820. &lt;br&gt;https://doi.org/10.3390/molecules20033811</mixed-citation></ref><ref id="hanspub.20535-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Li, H., Liu, C., Zhang, Y., Sun, Y., Wang, B. and Liu, W. (2015) Green Method for the Synthesis of Chromeno[2,3-c]- Pyrazol-4(1H)-Ones through Ionic Liquid Promoted Directed Annulation of 5-(Aryloxy)-1H-Pyrazole-4-Carbalde- hydes in Aqueous Media. Organic Letters, 17, 932-935. &lt;br&gt;https://doi.org/10.1021/acs.orglett.5b00033</mixed-citation></ref><ref id="hanspub.20535-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Xue, F., Ma, R., Sun, Y., Abdukader, A., Zhang, Y. and Liu, C. (2015) Syntheses of Carboxyl Functionalized Benzotriazol-Based Ionic Liquids and Their Application in Extraction-Oxidative Desulfurization. Chemical Journal of Chinese Universities, 36, 1298-1303.</mixed-citation></ref><ref id="hanspub.20535-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Rao, G.B.D., Acharya, B.N., Verma, S.K. and Kaushik, M.P. (2011) N,N’-Dichlorobis(2,4,6-Trichlorophenyl)Urea (CC-2) as a New Reagent for the Synthesis of Pyrimidone and Pyrimidine Derivatives via Biginelli Reaction. Tetrahedron Letters, 52, 809-812.</mixed-citation></ref><ref id="hanspub.20535-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Yadav, J.S., Reddy, B.V.S., Sridhar, P., Reddy, J.S.S., Nagaiah, K., Lingaiah, N. and Saiprasad, P.S. (2004) Green Protocol for the Biginelli Three-Component Reaction: Ag3PW12O40 as a Novel, Water-Tolerant Heteropolyacid for the Synthesis of 3,4-Dihydropyrimidinones. European Journal of Organic Chemistry, 2004, 552-557.  
&lt;br&gt;https://doi.org/10.1002/ejoc.200300559</mixed-citation></ref><ref id="hanspub.20535-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Li, W., Zhou, G., Zhang, P., Lai, Y. and Xu, S. (2011) One-Pot Synthesis of Dihydropyrimidiones via Environmentally Friendly Enzyme-Catalyzed Biginelli Reaction. Heterocycles, 83, 2067-2077. &lt;br&gt;https://doi.org/10.3987/COM-11-12267</mixed-citation></ref><ref id="hanspub.20535-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Gholap, A.R., Venkatesan, K., Daniel, T., Lahoti, R.J. and Srinivasan, K.V. (2004) Ionic Liquid Promoted Novel and Efficient One Pot Synthesis of 3,4-Dihydropyrimidin-2-(1H)-Ones at Ambient Temperature under Ultrasound Irradiation. Green Chemistry, 6, 147-150. &lt;br&gt;https://doi.org/10.1039/b314015f</mixed-citation></ref><ref id="hanspub.20535-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Da Silva, D.L., Fernandes, S.A., Sabino, A.A. and De Fatima, A. (2011) p-Sulfonic Acid Calixarenes as Efficient and Reusable Organocatalysts for the Synthesis of 3,4-Dihydropyrimidin-2(1H)-Ones/-Thiones. Tetrahedron Letters, 52, 6328-6330.</mixed-citation></ref><ref id="hanspub.20535-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Khabazzadeh, H., Saidi, K. and Sheibani, H. (2008) Microwave-Assisted Synthesis of Dihydropyrimidin-2(1H)-Ones Using Graphite Supported Lanthanum Chloride as a Mild and Efficient Catalyst. Bioorganic &amp; Medicinal Chemistry Letters, 18, 278-280.</mixed-citation></ref><ref id="hanspub.20535-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Chitra, S. and Pandiarajan, K. (2009) Calcium Fluoride: An Efficient and Reusable Catalyst for the Synthesis of 3,4-Dihydropyrimidin-2(1H)-Ones and Their Corresponding 2(1H)Thione: An Improved High Yielding Protocol for the Biginelli Reaction. Tetrahedron Letters, 50, 2222-2224.</mixed-citation></ref></ref-list></back></article>